Ontology highlight
ABSTRACT:
SUBMITTER: Cami-Kobeci G
PROVIDER: S-EPMC3070388 | biostudies-other | 2009 Mar
REPOSITORIES: biostudies-other
Journal of medicinal chemistry 20090301 6
Ligands from the naltrexamine series have consistently demonstrated agonist activity at kappa opioid receptors (KOR), with varying activity at the mu opioid receptor (MOR). Various 6 beta-cinnamoylamino derivatives were made with the aim of generating ligands with a KOR agonist/MOR partial agonist profile, as ligands with this activity may be of interest as treatment agents for cocaine abuse. The ligands all displayed the desired high affinity, nonselective binding in vitro and in the functional ...[more]